rotavirus gastroenteritis
Vaccines · 2006–2006
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| rotavirus vaccine, human, lyophilised powder and solvent for oral administration Prevention of rotavirus gastroenteritis in infants vaccinated at 2 and 4 months of age. | Jul 2006 | Not recommended | no section in document |
| rotavirus vaccine, human, lyophilised powder and solvent for oral administration Prevention of rotavirus gastroenteritis in infants vaccinated at 2 and 4 months of age. | Jul 2006 | Not recommended | no section in document |
| rotavirus vaccine, live, oral, pentavalent Prevention of rotavirus gastroenteritis in infants. The vaccine is proposed for vaccination of all infants at 2, 4, and 6 months of age. | Jul 2006 | Not recommended | no section in document |
| rotavirus vaccine, live, oral, pentavalent Prevention of rotavirus gastroenteritis in infants. The vaccine is proposed for vaccination of all infants at 2, 4, and 6 months of age. | Jul 2006 | Not recommended | no section in document |
| Human Rotavirus Vaccine Prevention of rotavirus gastroenteritis (RVGE) in infants, administered at 2 and 4 months of age on the National Immunisation Program. | Nov 2006 | Recommended with restriction | no section in document |
| Human Rotavirus Vaccine Prevention of rotavirus gastroenteritis in infants. Vaccination of all infants at 2 and 4 months of age. | Nov 2006 | Recommended with restriction | no section in document |
| rotavirus vaccine, live, oral, pentavalent Vaccination of infants at 2, 4 and 6 months of age to prevent rotavirus gastroenteritis. | Nov 2006 | Recommended | no section in document |
| rotavirus vaccine, live, oral, pentavalent Prevention of rotavirus gastroenteritis in infants at 2, 4, and 6 months of age. | Nov 2006 | Recommended | no section in document |
Registered, not subsidised
Medicines on the ARTG for this condition with no PBAC record at all. Registration and subsidy are separate decisions: a medicine can be legally available in Australia and never have been put to the committee.
| Medicine | On the ARTG since | Registrations |
|---|---|---|
| rotavirusROTARIX human rotavirus (live attenuated oral vaccine) oral liquid | 2008 | 2 |
| rotavirus g + rotavirus pROTATEQ rotavirus vaccine live oral pentavalent pre-filled dosing tube | 2006 | 1 |
The ARTG export holds current registrations only, so the year is the earliest entry still on the register rather than a first-registration date. The condition here comes from the registered label, which is usually broader than the population a sponsor asks to have subsidised.
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.